Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanif Esmail

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
The Lancet. Global Health|August 16, 2024
Preventive therapy: can tuberculosis efforts learn anything from the leprosy approach?Dominic Wakerley, Barbara de Barros, David A J Moore, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 19, 2025
World TB Day 2025 Theme "Yes! We Can End TB: Commit, Invest, Deliver" can be made a reality through concerted global efforts to advance diagnosis, treatment and research of tuberculosis infection and diseaseDelia Goletti, Alberto Matteelli, Jacqueline M Cliff, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2023
Reevaluating progression and pathways following <i>Mycobacterium tuberculosis</i> infection within the spectrum of tuberculosisKatherine C Horton, Alexandra S Richards, Jon C Emery, et al.
Current Opinion in HIV and AIDS|October 5, 2018
Recent progress in understanding immune activation in the pathogenesis in HIV-tuberculosis co-infectionElsa du Bruyn, Nashied Peton, Hanif Esmail, et al.
BMJ Global Health|July 22, 2025
Policies, practices, opportunities and challenges for tuberculosis screening: a global survey of national tuberculosis programmesLiana Macpherson, Cecily Miller, Yohhei Hamada, et al.
The Lancet. Respiratory Medicine|June 6, 2022
Tuberculosis prevalence: beyond the tip of the icebergRein M G J Houben, Hanif Esmail, Frank Cobelens, et al.
The Lancet. Respiratory Medicine|October 2, 2020
A threat to decentralised care for drug-resistant tuberculosisAdam T Gray, Tom Boyles, Susanne Luedtke, et al.
BMC Infectious Diseases|February 23, 2024
Diagnosis and management of tuberculosis infection in inclusion health populations in LondonAdam Gray, Julian Surey, Martha Veitch, et al.
The Lancet. Infectious Diseases|March 17, 2017
Tuberculosis is changingTimothy M Walker, Ana Louisa Gibertoni Cruz, Tim E Peto, et al.
The European Respiratory Journal|November 9, 2023
Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testingJay Achar, James A Seddon, Gwenan M Knight, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
The Lancet. Global Health|August 16, 2024
Preventive therapy: can tuberculosis efforts learn anything from the leprosy approach?Dominic Wakerley, Barbara de Barros, David A J Moore, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 19, 2025
World TB Day 2025 Theme "Yes! We Can End TB: Commit, Invest, Deliver" can be made a reality through concerted global efforts to advance diagnosis, treatment and research of tuberculosis infection and diseaseDelia Goletti, Alberto Matteelli, Jacqueline M Cliff, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2023
Reevaluating progression and pathways following <i>Mycobacterium tuberculosis</i> infection within the spectrum of tuberculosisKatherine C Horton, Alexandra S Richards, Jon C Emery, et al.
Current Opinion in HIV and AIDS|October 5, 2018
Recent progress in understanding immune activation in the pathogenesis in HIV-tuberculosis co-infectionElsa du Bruyn, Nashied Peton, Hanif Esmail, et al.
BMJ Global Health|July 22, 2025
Policies, practices, opportunities and challenges for tuberculosis screening: a global survey of national tuberculosis programmesLiana Macpherson, Cecily Miller, Yohhei Hamada, et al.
The Lancet. Respiratory Medicine|June 6, 2022
Tuberculosis prevalence: beyond the tip of the icebergRein M G J Houben, Hanif Esmail, Frank Cobelens, et al.
The Lancet. Respiratory Medicine|October 2, 2020
A threat to decentralised care for drug-resistant tuberculosisAdam T Gray, Tom Boyles, Susanne Luedtke, et al.
BMC Infectious Diseases|February 23, 2024
Diagnosis and management of tuberculosis infection in inclusion health populations in LondonAdam Gray, Julian Surey, Martha Veitch, et al.
The Lancet. Infectious Diseases|March 17, 2017
Tuberculosis is changingTimothy M Walker, Ana Louisa Gibertoni Cruz, Tim E Peto, et al.
The European Respiratory Journal|November 9, 2023
Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testingJay Achar, James A Seddon, Gwenan M Knight, et al.
Pageof 7